Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 5
2004 11
2005 15
2006 14
2007 13
2008 14
2009 19
2010 15
2011 23
2012 18
2013 12
2014 17
2015 18
2016 14
2017 10
2018 6
2019 3
2020 1
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Identification of neuroblastoma cell lines with uncommon TAZ+/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells.
Canzonetta C, Pelosi A, Di Matteo S, Veneziani I, Tumino N, Vacca P, Munari E, Pezzullo M, Theuer C, De Vito R, Pistoia V, Tomao L, Locatelli F, Moretta L, Caruana I, Azzarone B. Canzonetta C, et al. Among authors: pistoia v. J Immunother Cancer. 2021 Jan;9(1):e001313. doi: 10.1136/jitc-2020-001313. J Immunother Cancer. 2021. PMID: 33452207 Free PMC article.
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.
Veneziani I, Infante P, Ferretti E, Melaiu O, Battistelli C, Lucarini V, Compagnone M, Nicoletti C, Castellano A, Petrini S, Ognibene M, Pezzolo A, Di Marcotullio L, Bei R, Moretta L, Pistoia V, Fruci D, Barnaba V, Locatelli F, Cifaldi L. Veneziani I, et al. Among authors: pistoia v. Cancer Immunol Res. 2021 Feb;9(2):170-183. doi: 10.1158/2326-6066.CIR-20-0313. Epub 2020 Dec 10. Cancer Immunol Res. 2021. PMID: 33303573
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.
Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, Mancini C, Martella E, Ribatti D, Vacca A, Pistoia V, Giuliani N. Marchica V, et al. Among authors: pistoia v. Cancers (Basel). 2019 Mar 6;11(3):321. doi: 10.3390/cancers11030321. Cancers (Basel). 2019. PMID: 30845779 Free PMC article.
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.
Boldrini R, De Pasquale MD, Melaiu O, Chierici M, Jurman G, Benedetti MC, Salfi NC, Castellano A, Collini P, Furlanello C, Pistoia V, Cifaldi L, Terenziani M, Fruci D. Boldrini R, et al. Among authors: pistoia v. Oncoimmunology. 2018 Dec 13;8(2):e1542245. doi: 10.1080/2162402X.2018.1542245. eCollection 2019. Oncoimmunology. 2018. PMID: 30713803 Free PMC article.
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma.
Morandi F, Horenstein AL, Costa F, Giuliani N, Pistoia V, Malavasi F. Morandi F, et al. Among authors: pistoia v. Front Immunol. 2018 Nov 28;9:2722. doi: 10.3389/fimmu.2018.02722. eCollection 2018. Front Immunol. 2018. PMID: 30546360 Free PMC article. Review.
CHL1 gene acts as a tumor suppressor in human neuroblastoma.
Ognibene M, Pagnan G, Marimpietri D, Cangelosi D, Cilli M, Benedetti MC, Boldrini R, Garaventa A, Frassoni F, Eva A, Varesio L, Pistoia V, Pezzolo A. Ognibene M, et al. Among authors: pistoia v. Oncotarget. 2018 May 25;9(40):25903-25921. doi: 10.18632/oncotarget.25403. eCollection 2018 May 25. Oncotarget. 2018. PMID: 29899830 Free PMC article.
209 results